Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 561

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 561
---
 from the sale of the Private Placement Units held in the Trust Account will be included in the liquidating distribution to the holders of the Public Shares. The Sponsor and the Company’s officers and directors will agree, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Units, including the component securities therein until 30 days after the completion of the Business Combination. Promissory Notes The Sponsor has advanced funds to the Company for the payment of expenses incurred in connection with the Initial Public Offering, which amount is evidenced by non -interest-bearingpromissory notes in the aggregate principal amount of $ 1,200,000. The promissory notes were due at the earlier of November 29, 2023or upon the closing of the Initial Public Offering. These notes were discharged and cancelled in connection with the private placement that closed simultaneously with the Initial Public Offering. On June 23, 2023, the Sponsor loaned to the Company $ 200,000to fund working capital requirements and in exchange therefor the Company issued to the Sponsor an unsecured promissory note in the principal amount of $ 200,000. This note is non -interest-bearingand is payable in full on the earlier of: (i) December 31, 2024 or (ii) the date on which the Company consummates an initial Business Combination. In the event that the Company does not consummate an initial Business Combination, the note will be repaid only from amounts remaining outside of the Company’s Trust Account, if any. At the Sponsor’s discretion, the principal balance of the note may be converted at any time prior to the consummation of the Business Combination into units identical to the private placement units at a price of $ 10.00per Unit. As of September 30, 2024 and December 31, 2023, the outstanding balance of this note was $ 0. F-16 BELLEVUE LIFE SCIENCES ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2024 (UNAUDITED) NOTE 4 — RELATED PARTY TRANSACTIONS (cont.) On November 13, 2023, Bellevue Capital Management LLC (“BCM”) loaned to the Company $ 180,000and in exchange therefor the Company issued to BCM an unsecured promissory note in the principal amount of $ 180,000. The proceeds of this loan were used to fund the payment to extend